cc-8k_20220427.htm
false 0001627223 0001627223 2022-04-27 2022-04-27

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

 

April 27, 2022

Date of Report (Date of Earliest Event Reported)

The Chemours Company

(Exact Name of Registrant as Specified in Its Charter)

 

Delaware

 

001-36794

 

46-4845564

(State or Other Jurisdiction

 

(Commission

 

(I.R.S. Employer

Of Incorporation)

 

File Number)

 

Identification No.)

 

1007 Market Street

Wilmington, Delaware, 19801

(Address of principal executive offices)

 

Registrant’s telephone number, including area code: (302) 773-1000

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class

 

Trading Symbol(s)

 

Name of Exchange on Which Registered

Common Stock ($.01 par value)

 

CC

 

New York Stock Exchange

 

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 


 

 

Item 5.07Submission of Matters to a Vote of Security Holders.

 

The Chemours Company (the “Company”) held its annual meeting of shareholders on April 27, 2022 (the “Annual Meeting”).

 

At the Annual Meeting, shareholders:

 

 

elected all ten director nominees to serve a one-year term;

 

approved the Company’s annual “say-on-pay” vote on an advisory basis;

 

approved “one year” as the frequency for the Company’s annual “say-on-pay” vote on an advisory basis; and

 

ratified PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm.

 

The final voting results for each proposal were as follows:

 

Proposal 1 – Election of Directors to Serve One-Year Term

 

Nominee

For

Against

Abstain

Total

Broker Non-Votes

Curtis V. Anastasio

110,569,994

(99.00%)

907,291

208,218

111,685,503

22,085,486

Bradley J. Bell

110,670,050

(99.09%)

803,600

211,852

111,685,502

22,085,487

Mary B. Cranston

110,752,105

(99.16%)

710,794

222,600

111,685,499

22,085,490

Curtis J. Crawford

110,546,897

(98.98%)

917,522

221,080

111,685,499

22,085,490

Dawn L. Farrell

110,672,247

(99.09%)

795,742

217,515

111,685,504

22,085,485

Erin N. Kane

110,709,593

(99.13%)

766,759

209,149

111,685,501

22,085,488

Sean D. Keohane

110,611,290

(99.04%)

872,333

201,880

111,685,503

22,085,486

Mark E. Newman

110,959,647

(99.35%)

520,640

205,217

111,685,504

22,085,485

Guillaume Pepy

110,901,171

(99.30%)

572,190

212,135

111,685,496

22,085,493

Sandra P. Rogers

110,787,319

(99.20%)

688,532

209,648

111,685,499

22,085,490

 

Proposal 2 – Advisory Vote to Approve Named Executive Officer Compensation

For

Against

Abstain

Total

Broker Non-Votes

105,824,703

(94.75%)

5,357,332

503,454

111,685,489

22,085,500

 

Proposal 3 – Advisory Vote on Frequency of Advisory Vote to Approve Named Executive Officer Compensation

One Year*

Two Year

Three Year

Abstain

Total

Broker Non-Votes

108,397,596

(97.06%)

278,167

2,607,691

402,039

111,685,493

22,085,496

* The Company will include a stockholder vote on the compensation of executives in its proxy materials every year until the next required vote on the frequency of stockholder votes on the compensation of executives.

 

Proposal 4 – Ratification of Selection of Independent Registered Public Accounting Firm

For

Against

Abstain

Total

Broker Non-Votes

132,496,474

(99.05%)

1,056,898

217,617

133,770,989

n/a

 


 


 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

THE CHEMOURS COMPANY

 

By:

 

/s/ Sameer Ralhan

 

 

Sameer Ralhan

 

 

Senior Vice President, Chief Financial Officer

 

 

Date:

 

April 29, 2022